Insider Transactions in Q1 2026 at Mineralys Therapeutics, Inc. (MLYS)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2026
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
11,367
-18.39%
|
$363,744
$32.61 P/Share
|
|
Jan 13
2026
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,709
-11.09%
|
$246,688
$32.75 P/Share
|
|
Jan 13
2026
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,709
+5.4%
|
$92,508
$12.23 P/Share
|
|
Jan 12
2026
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,348
-9.31%
|
$203,136
$32.32 P/Share
|
|
Jan 12
2026
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,348
+8.52%
|
$6,348
$1.08 P/Share
|
|
Jan 12
2026
|
Adam Scott Levy CFO and Secretary |
SELL
Open market or private sale
|
Direct |
10,758
-55.47%
|
$344,256
$32.14 P/Share
|
|
Jan 12
2026
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,236
-1.25%
|
$519,552
$32.68 P/Share
|
|
Jan 09
2026
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,170
-3.39%
|
$71,610
$33.27 P/Share
|
|
Jan 09
2026
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,170
+3.28%
|
$34,720
$16.0 P/Share
|
|
Jan 05
2026
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
192,715
-50.55%
|
$6,745,025
$35.18 P/Share
|
|
Jan 05
2026
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
185,331
+18.12%
|
$2,038,641
$11.39 P/Share
|
|
Jan 02
2026
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
70,037
-50.3%
|
$2,451,295
$35.87 P/Share
|
|
Jan 02
2026
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
67,390
+10.74%
|
$741,290
$11.39 P/Share
|